| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.6M | -1.8% |
| SG&A Expense | $107.4M | +74.2% |
| Operating Income | -$122.5M | -62.0% |
| Pre-tax Income | -$99.1M | -6.1% |
| Income Tax | $0 | — |
| Net Income | -$98.8M | -5.8% |
| EPS (Basic) | -$0.83 | +33.1% |
| EPS (Diluted) | -$0.83 | +33.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $443.1M | -21.4% |
| Current Assets | $579.5M | -0.6% |
| Total Assets | $827.7M | +32.0% |
| Current Liabilities | $62.6M | +142.6% |
| Total Liabilities | $107.6M | +31.9% |
| Stockholders' Equity | $717.5M | +31.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.0M | -42.6% |
| Capital Expenditures | $180.8M | +1212.4% |
| Investing Cash Flow | -$175.0M | -418.0% |
| Financing Cash Flow | $250.1M | -61.5% |
| Free Cash Flow | -$270.8M | -252.1% |